Search Results - "Dobogai, L C"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen by Beri, R, Chunduri, S, Sweiss, K, Peace, D J, Mactal-Haaf, C, Dobogai, L C, Shord, S, Quigley, J G, Chen, Y H, Mahmud, N, Rondelli, D

    Published in Bone marrow transplantation (Basingstoke) (01-02-2010)
    “…A pretransplant test dose of i.v. BU was previously used in pediatric patients undergoing a reduced-intensity allogeneic hematopoietic SCT (HSCT). Here, we…”
    Get full text
    Journal Article
  2. 2

    Fludarabine i.v. BU conditioning regimen: myeloablative, reduced intensity or both? by Chunduri, S, Dobogai, L C, Peace, D, Saunthararajah, Y, Quigley, J, Chen, Y-H, Mahmud, N, Hurter, E, Beri, R, Rondelli, D

    Published in Bone marrow transplantation (Basingstoke) (01-06-2008)
    “…In this study, we utilized a conditioning regimen with fludarabine and myeloablative dose i.v. BU (12.8 mg/kg) (FluBU) in 36 adult patients (median age: 44…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma by SARAF, S, CHEN, Y.-H, DOBOGAI, L. C, MAHMUD, N, PEACE, D, SAUNTHARARAJAH, Y, HOFFMAN, R, CHUNDURI, S, RONDELLI, D

    Published in Bone marrow transplantation (Basingstoke) (01-06-2006)
    “…Multiple myeloma (MM) has a double incidence in African-American (AA) than in non-AA patients and previous studies have shown a higher mortality in the former…”
    Get full text
    Journal Article
  5. 5
  6. 6